Article Text

other Versions

PDF
The Role of Cardiac MRI scanning in Thalassaemia
  1. John-Paul Carpenter (j.carpenter{at}rbht.nhs.uk)
  1. Royal Brompton, United Kingdom
    1. Sanjay K Prasad (s.prasad{at}rbh.nthames.nhs.uk)
    1. Royal Brompton, United Kingdom
      1. Dudley Pennell (dj.pennell{at}rbht.nhs.uk)
      1. Royal Brompton, United Kingdom

        Abstract

        According to WHO data, approximately 56,000 babies are born each year with a major thalassaemia, including at least 30,000 who require lifelong transfusions to survive. Of those transfused, under 40% obtain adequate chelation therapy. An estimated 100,000 patients worldwide are currently living with regular transfusions, but at least 3,000 die each year in their teens or early 20s from uncontrolled iron overload, mainly due to heart failure. With no physiological excretory pathway, iron from transfused blood accumulates in the liver, heart, endocrine and other organs causing tissue damage and impairment in function. Chelating agents can remove the excess iron and prevent complications, the most serious of which is death from heart failure due to myocardial siderosis. Progressive cardiac iron loading eventually leads to left ventricular (LV) dilatation and reduction in LV ejection fraction but this is a late manifestation of severe myocardial siderosis and once clinical evidence of heart failure has developed, the prognosis is poor.

        Statistics from Altmetric.com

        Request permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

        Linked Articles